Are you ready for the start of the new year?

[editor's point of view of chinapharma.com] the festive Spring Festival has passed While people are still dealing with the "post Festival syndrome", the Chinese Antarctic research team has set a new record in the offshore South China Science and technology examination China's optical transmission system has achieved a breakthrough, with 13.5 billion people in one optical fiber being able to talk at the same time; Tianhe-1 has over 1400 online tasks every day, and has made outstanding achievements in supporting national technological innovation and service industry China has broken a number of world records at the beginning of the year, which not only shows the rise of comprehensive national strength, but also opens a good start for 2017 Many netizens said, "the new year is really a boost!" "fierce! My motherland!" "see the motherland so strong, so hard, all walks of life should roll up their sleeves and work hard!" for the pharmaceutical machinery industry, in the new year, a number of pharmaceutical policies will be implemented, and the challenges and competition in the industry will follow To make a good start, pharmaceutical machinery enterprises need to grasp Opportunities, objectives, and practical innovation and development are needed to achieve new breakthroughs (is the pharmaceutical machinery enterprise ready for the start of the new year? Looking back on the development of China's pharmaceutical machinery industry in recent years, China's pharmaceutical machinery industry has made great progress, and its export scope and quantity are constantly expanding and increasing, with a broad prospect Some experts said that China's pharmaceutical machinery industry is gradually becoming the main force of the world's pharmaceutical machinery industry With the domestic and foreign sales of pharmaceutical machinery products gradually picking up, the requirements of the international market for pharmaceutical machinery products in China are gradually changing, and local pharmaceutical machinery enterprises are increasingly entering the international market In addition, the concentration of domestic pharmaceutical machinery industry has been increasing in recent years, and a number of large pharmaceutical machinery enterprises and groups have emerged gradually Many pharmaceutical machinery enterprises and groups have increased their investment in innovation, developed new products, strengthened their core competitive advantages and realized large-scale production In addition to the enhancement of the strength of pharmaceutical machinery enterprises, the intensively issued pharmaceutical policies are also adding fuel and salary to the pharmaceutical machinery industry The pharmaceutical industry is related to national health With the increasing proportion of the aging population in the total population and the increasing demand of the drug market, in order to accelerate the adjustment and optimization of the structure of the pharmaceutical industry and improve the added value of pharmaceutical products, China has issued a series of policies to promote the sustainable and healthy development of the pharmaceutical industry This has also given the pharmaceutical machinery industry a shot in the arm On the one hand, the frequent policies and the acceleration of the internationalization process have provided the pharmaceutical machinery industry and pharmaceutical machinery enterprises with continuous orders, improved the development space, and on the other hand, created favorable conditions for the industry and enterprises to improve the quality and learn advanced foreign technologies However, the huge market potential and the gravity of the central position will attract more multinational companies and manufacturing centers to transfer to China At that time, the competition of pharmaceutical machinery industry can be imagined The new year's industry war has begun In order to meet the challenges and competition in the future, pharmaceutical machinery enterprises need to seize the opportunity and formulate new goals in combination with the actual situation, so as to achieve new breakthroughs According to the prediction of relevant organizations, the revenue of China's pharmaceutical manufacturing industry will reach 2967.5 billion yuan in 2017, the annual compound growth rate in the next five years (2017-2021) will be about 10.15%, and the revenue in 2021 will reach 4368.1 billion yuan Although the income of pharmaceutical manufacturing industry is considerable, the pharmaceutical machinery industry will have to work hard to meet this prediction in the future Some insiders pointed out that under the full implementation of GMP and GSP certification, China's pharmaceutical industry has eliminated a number of backward pharmaceutical machinery enterprises, but the phenomenon of many, small, scattered and disorderly enterprises is still prominent In addition, some pharmaceutical machinery enterprises are mainly engaged in the production of mature and low technical requirements of mechanical products, lack of variety innovation and technological innovation, and the development of the industry needs to be solved So, facing the current situation and unknown challenges, how should pharmaceutical machinery enterprises prepare? Experts suggest that pharmaceutical machinery enterprises should make good development goals, demand benefits from scale, spare no effort to reduce production costs, control management costs and sales costs, and improve the cost performance of products At the same time, it is very important to follow the industry trend Energy conservation and environmental protection is a new economic growth point in China The rapid growth of environmental protection industry will provide a good opportunity for the development of pharmaceutical machinery industry Pharmaceutical machinery energy conservation and environmental protection industry will become an important support for the development of green economy, low-carbon economy and circular economy in China In addition, enterprises need to keep up with the pace of foreign technology development, improve technology level through joint ventures and cooperation, and reduce R & D risks and costs.